LoginCreate an account

  Username: Password:
 
Home mySSlife Health FDA probes heart problems with asthma drug Xolair

FDA probes heart problems with asthma drug Xolair

E-mail Print PDF
User Rating: / 0
PoorBest 

WASHINGTON (AP) ‚  Federal regulators are reviewing data that suggest the asthma medication Xolair can cause heart attacks, strokes and other potentially deadly problems.

The Food and Drug Administration says preliminary results from a study of 5,000 patients taking the drug suggests an increased risk of heart problems and stroke. The drug's manufacturer Genentech, a unit of Swiss pharmaceutical giant Roche, designed the study to track the long-term safety of the drug over five years.

A representative for Genentech says final results are not expected until 2012. The South San Francisco-based company says it will continue gathering safety information about Xolair.

The FDA says patients should continue taking the drug as directed.


Copyright 2009 The Associated Press.

 

 

 
Sanjay Gupta MD (video)
Finally, straight answers about your health.
  • I want candy!
    For Halloween, CNN's Dr. Sanjay Gupta and CNN Eatocracy's Kat Kinsman talk candy nostalgia and the worst candy available.
  • Brother doctors freed from Iran, reunite
    Sanjay Gupta interviews two brothers, both doctors, who were imprisoned in Iran while treating HIV/AIDS patients.
  • The next killer virus
    CNN's Dr. Sanjay Gupta talks with virologist Nathan Wolfe about finding infectious diseases before they spread too far.
FOX News
FOXNews.com - Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
FOX News
  • How often does enterovirus D68 cause paralysis?
    Several children in Denver have developed limb weakness or paralysis after contracting respiratory illness, and four of the children have tested positive for enterovirus D68, the virus that has now sickened more than 400 people in 40 states, according to the Centers for Disease Control and Prevention
  • Shares of companies testing Ebola vaccines rise
    Shares of some companies that are studying potential vaccines for Ebola climbed after federal officials announced that the first case of the disease has been diagnosed in the U.S.
  • What you need to know about Ebola
    Important facts that you need to know about Ebola.

Search...

WebSite

mySSnews Login



User Menu